26.09.2014 - Pfizer can change the downward trend

Pfizer's stock price has broken through the upper limit of the downward channel and after some growth corrected down and now is trying to gain a foothold outside of the downward channel. In case of success, and the resumption of growth, confirmation of the signal to open long positions with the targets at 32.85, 35.00 and 38.00, will be fixation of quotations above 31.00. Stop should be set below 29.00. We expect the resumption of growth of price in the near future, but will recommend to wait for confirmation of a buy signal.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.